![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
20
Tianjin Tianyao Pharmaceuticals Co., Ltd. Tianjin Cn, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Prednisolone, Process II, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2020-217 - Rev 00
This Chemical Type CEP, issued on November 05, 2020, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 353 associated with this CEP further emphasizes